Dr. Pankaj Taneja
- Area Of Interest
- Award & Recognition
- Research & Publications
Dr. Pankaj Taneja is eminent teacher and scientist. He has 14years of experience at national and international levels in biotechnology. His area of research is in signal transduction pathways in cancer prevention. He has been awarded with prestigious Ramalingaswamy fellowship. In his previous experience he worked in Johns Hopkins and Wake Forest Universities, USA .
- 14 years Ramalingaswamy fellow DBT and INMAS(2011-2016)
- Scientist and Research Asso Professor
- Wake Forest University, USA (2005-2010)
- Post Doctoral fellow, Johns Hopkins University, USA (2003-2005)
- Research fellow and Lecturer (1998-2003) IITR Lucknow and Hamdard University, Delhi
- Signal transduction and genetic toxicology
- Awarded Presitigious Presidential Ramalingaswamy fellowship and grant (Rs. 74.5 Laks Total) from DBT CGO Complex Delhi
- Invited Visiting Scientist (June-August 2015), Radiation Oncology Division, University of Florida, USA.Guest editor of "Journal Alternative and Complementary Medicine in radiation pathologies" Hindwai Publications 2014, Egypt, UK and USA
- Consultant 2012; Nutrametrix Health Solutions, USA
- Certified Course on Occupational and Enviromental Medicine Johns Hopkins School of Public Health; 2004
- Supervised & Taught various Summer Interns, Grad& Post Grad students in their project training in Wake Forest, Johns Hopkins & Hamdard Universities.
- Awarded Best paper in the XXVIIth Annual Conference of Environmental Mutagen Society of India entitled “ Antigenotoxic potential of diallyl sulfide: a mechanistic approach”2002
- Selected trainee for Genotoxicity evaluation in Central Drug Research Institute, Lucknow India, 1999
- Selected Fellow award for Antigenotoxic evaluation of Plant Phenolics, ITRC, Lucknow India2004
Reviewer of manuscript of scientific journals:-
- Investigational New Drugs
- Food and Chemical Toxicology
- Journal of Agricultural Food Chemistry
- Molecular Carcinogenesis
- Cancer Biology and Therapy
- Cancer chemotherapy and Pharmacology
- Environmental Monitoring and Assessment
- Ramalingaswamy grant (DBT) Rs 25 Lakhs including salary (2011-contd) Signal transduction in cancer prevention in response to radiation induced cancer
- KGO80179: Amount-$200,000; Komen Breast Cancer Research foundation(2008-2011). Title : Critical role of Dmp1 in the prevention of CyclinD1 induced breast Cancer.
- RSG-07-207-01 Amount $850,000;American Cancer Society (2006-2010) Title: Role of Dmp1 in Her2 induced breast cancer
- Fry Taneja P, EA, Inoue K (2016). Oncogenic and tumor suppressive mouse models of breast cancer engaging Her2/Neu. Int. J.Cancer. Aug 23. doi: 10.1002/ijc.30399.
- Khan AR, Taneja P(2016). In vivo inhibition of Glutathione-S-transferaseP1 by Bovine Lactoferricin in Swiss Albino tumor bearing mice. Journal of App. Pharm Sci 6(11). 210-213.
- Khan AR, Sadiq IZ, Abdulahi LI, Danlam D, Taneja P (2016). Chemopreventive role of Bovine Lactoferrcin against 7,12 Dimethlyl Benz anthracene induced skin cancer in female swiss albino mice. Int. J. Pharm Pharmaceut. Sci . 8(8); 215-222.
- Shivam K, Khan AR, Taneja P(2016). Development in diagonosis and treatement Alzheimer,s disease. IOSR J. Pharmacy 6(7) 43-50.
- Khan AR, Taneja P. (2015). Cationic Peptide LactoferricinB inhibits Glutathione- transferase P1 from human placenta and breast cancer cell line MDA MB-231 in preventing anticancer drug metabolism. Int. J. Pharm Pharmaceut. Sci . 7(8); 1-4.
- Maglic D, Stovall DB, Cline JM, Fry EA, Mallakin A, Taneja P, Caudell DL, Willingham MC, Sui G, Inoue K. (2015). DMP1β, a splice isoform of the tumour suppressorDMP1 locus, induces proliferation and progression of breast cancer. J Pathol.236(1); 90-102
- Taneja P, Gulzar M and Taneja P. (2015). Phytochemicals in therapy of radiation induced damage and cancer. (Accepted )SM group Publications, Irvin, Texas, USA
- Yadav AK, Vashishta V, Joshi N, Taneja P (2014). AR-A 014418 Used against GSK3beta Downregulates Expression of hnRNPA1 and SF2/ASF Splicing Factors. J Oncology.695325. doi: 10.1155/2014/. Epub Jan 2.
- Fry EA, Taneja P, Maglic D, Zhu S, Sui G, Inoue K. (2013) Dmp1α inhibits HER2/neu-induced mammary tumorigenesis. PLoS One. ;8(10):e77870.
- Zhu S, Mott RT, Fry EA, Taneja P, Kulik G, Sui G, Inoue K. (2013). Cooperation betweenDmp1 loss and cyclin D1 overexpression in breast cancer. Am J Pathol. 183(4):1339-50.
- Inoue K, Fry EA, Taneja P. (2013). Recent progress in mouse models for tumor suppressor genes and its implications in human cancer. Clinical Medical Insights: Oncology. 7; 103-122.
- Maglic D*, Zhu S*, Fry E*, Taneja P*, Kai F, Kendig RD, Sugiyama T, Miller LD, Willingham M, Inoue K. (2012). Prognostic value of hDMP1-Arf-hDM2-p53 pathway in breast cancer. Oncogene Oct8, 1-10 * Equal Contribution
- Taneja P, Zhu S, Maglic D, Fry E, Kendig R, Inoue K (2011). Transgenic and Knockout mice models to reveal the functions of tumor Suppressor genes. Clinical Medical Insights: Oncology. 5; 235-257.
- Taneja P, Maglic D, Sugiyama T, Kai F, Frazier D.P, Kendig R.D,Willingham S, Inoue K.(2010). Dmp1 is the critical regulator of Her2/Neu P53-Arf signaling. Cancer Research 70;9084-9094.
- Taneja P, Maglic D, Sugiyama T, Kai F, Zhu S, Kendig R.D, Fry E, Inoue K.(2010). Classical and novel prognostic markers of breast cancer and their clinical significance. Clinical Medical Insights: Oncology 4: 15-34.
- Mallakin A, Sugiyama T, Kai F, Taneja P, Frazier D, Maglic D Kendig R, Inoue K. (2010).The Arf inducing transcription factor Dmp1 encodes transcription regulator Amphiregullin, Thrombospondin1 and JunB. Int J Cancer ,126; 1403-1416.
- Taneja P, Sugiyama T, Kai F, Frazier D.P, Kendig R.D, Maglic D, Taneja N.K, Inoue K. (2009). MMTV mouse models for human breast cancer and their diagnostic values. Expert Reviews Mol Diag. 9 (5),423-440.
- Prasad S, Taneja P, George S, Shukla Y (2009). Regulation of Cell Signalling molecules by Natural compounds:Chemopreventive and Chemotherapeutic Approach.Cancer Therapy. 7, 467-487.
- Sugiyama T, Taneja P, Frazier DP, Kendig RD, Morgan RL, Matise LA, Lagedrost SJ, Inoue K. (2008) Oncogenic and non-oncogenic signaling pathways that regulate Dmp1 (Dmtf1) (review).Clinical Medicine: Oncology,2, 209-219.
- Inoue K, Sugiyama T, Taneja P, Morgan RL, Frazier DP. (2008) Emerging roles of DMP1 in lung cancer. Cancer Research, 68, 4487-4490.
- Taneja P, Mallakin A, Matise LA, Frazier DP, Choudhary M, Inoue K. (2007) Repression of Dmp1 and Arf transcription by anthracyclins: critical roles of the NF-kappaB subunit p65. Oncogene, 26,7457-7466.
- Mallakin A*, Sugiyama T*, Taneja P*, Matise LA*, Frazier DP, Choudhary M, Hawkins GA, D'AgostinoRB Jr, Willingham MC, and Inoue K. (2007) Mutually exclusive inactivation of DMP1 and Arf/p53 in lung Cancer. Cancer Cell, 12, 381-394.
- * Equal Contribution
- Mallakin A, Taneja P, Matisie A , Willingham M, Inoue K. (2006) .Expression of Dmp1 in specific differentiated, non-proliferating cells and its regulation by E2Fs. Oncogene,25, 7703-7713.
- Shukla Y, Taneja P, Arora A, Sinha N (2004). Mutagenic Potential of Mancozeb in Salmonella typhimurium. J Env Pathol. Toxicol. Oncol 23, 294-302.
- Taneja P, Arora A, Shukla Y. (2003).Antimutagenic effects of black tea in the Salmonella typhimurium reverse mutation assay .Asian. Pac. J Cancer Prev. 4, 193-198.
- Shukla Y, Arora A, Taneja P. (2003). Antigenotoxic potential of certain dietary constituents. Teratogen. Carcinogen. Mutagen. 23,323-335.
- Shukla Y, Taneja P (2002). Anticarcinogenic effect of black tea on pulmonary tumors in Swiss albino mice. Cancer Lett., 176, 137-141
- Shukla Y, Arora A, Taneja P, (2002). Antimutagenic potential of Curcumin on Chromosomal aberrations in Wistar rats. Mutat. Res. 515,197-202.
- Shukla Y, Taneja P. (2002). Antimutagenic effect of garlic extract on Chromosomal aberrations. Cancer Lett 176, 31-36.
- Shukla Y, Taneja P.(2002) Mutagenic evaluation of cypermethrin in mouse dominant lethal assay.J Env Pathalog Toxicol. Onclol., 21, 259-265.
- Shukla Y, Taneja P (2001) Antimutagenic effect of black tea extract using” rodent dominant lethal mutation assay. Toxicology, 168, 269-274
- Shukla, Y., Taneja, P (2000). Mutagenic evaluation of deltamethrin using rodent dominant lethal assay. Mutat. Res, 467, 119- 127
- Taneja P, Frazier DP, Sugiyama T, Lagedrost S, Inoue K. (2008). Control of cellular physiology by transcription factors E2F and their roles in carcinogenesis. Research Signpost. (Review). ISBN: 978-81-308-0230-5; Pages-179-197.
- Taneja P, Kendig R, Zhu S, Maglic D, Fry S, Inoue K. (2012). Oncogenes and Tumor Suppressor genes in Small Cell Lung Carcinoma. Lung Diseases-Selected state of art Reviews: INTECH; ISBN: 978-953-51-0180-2; Pages 148-170
- American Association for Cancer Research
- American Chemical Society
- Environmental Mutagen Society
- International Society of Regulatory Toxicology and Pharmacology
- International Society of Radiation biology
- Indian National Science Congress
It was a great time we spent in Sharda University. Sharda has very wonderful faculty and they are very cooperative and campus environment is very positive. Training and placement department continuousHarshdeep Batra MBA (2014-2015)
It gives me great pleasure to say with pride that I have completed my post-graduation from School of Business Studies, Sharda University. The relationship between faculties and student is very cordialDeeksha Gupta MBA - Marketing & Finance (2014-15)
Taking admission into Sharda is like paying for an exclusive world tour. The university is comprised of different people from different nationalities which makes it a global community for diverse learIkechukwu M. Torti MBA – International Business (2014-15)
Building my career in Sharda University enriched my life. I can somehow see that my future is totally reliant on the career for which I am grateful to every faculty member of Chemistry Department, SchKanjur Wangdi Master of Science (Integrated), Chemistry
Studying architecture in Sharda has widened my perspective and has given me an idea of the importance of architecture in today’s day and age. The faculties and staff are very helpful and are alwShreeyukti Shah Architecture, 2014-15
Architecture is a field with uniqueness and individuality, the passion for which comes within the individual. Being a part of this course in Sharda University is like know your own individuality. TheZainab Manzoor Architecture, 2014-15
Hi.. ! I am Mohd. Faizan studying in school of architecture and planning is currently in 3rd year in sharda university. It has been a great experience. Here in sharda we have great faculty membeMohd. Faizan Architecture, 2014-15
Sharda University is the best university across the india and is known for its excellence . It has all the best facilities under one roof - state of infrastructure , erudite faculty , professional teaYamini Sharma Architecture, 2014-15
I can positively say Sharda University has made me a better person. It has helped me develop a positive attitude towards my studies and discover more about myself. Teachers are very caring and inMohammad Arish Architecture, 2014-15
Hello! I I am student of Sharda University pursuing Architecture. I am currently in 3rd year. It has been a great experience overall here in Sharda. we have a panel of great faculty members who aAparna Chatterjee Architecture, 2014-15